Department of Genetics, Faculty of Science, Shahid Chamran University, Ahvaz, Iran
Linkage studies and epidemiological findings indicate that some possible genes in schizophrenia (SCZ) and bipolar mood disorder (BPD) are common. Numerous evidences for linkage of two diseases on chromosome 22 have been found. These findings suggest that one or more genes in the 22q11.21 region may be involved in the development of both disorders. In the present case-control study, association between the mentioned disorders and a genetic polymorphism (rs165599) of catechol O-methyltransferase (COMT, OMIM: 116790) was studied. Here 100 BPD patients, 100 SCZ patients, and 100 healthy controls were included in the study. The samples were matched in terms of gender and ethnicity. Statistical analysis showed that there was a significant association this polymorphism and risk of SCZ. The AG (OR=7.41, 95% CI: 3.21-17.1, P
1. Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC, McCormack CM, Smith HJ, Filippich C, James MR, Mowry BJ. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry 2005;10:589-597.
2. Basco MR. The Bipolar Workbook: Tools for Controlling Your Mood Swings. ISBN 1-59385-162-6, 2006. p.12.
3. Yatham LN, Kennedy SH, Shaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G. Canadian Network for Mood and Anxiety Treatments Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11:225-255.
4. Williams M. Commentary: Genome-based CNS drug discovery: D-Amino acid oxidase (DAAO) as a novel target for antipsychotic medications: Progress and challenges. Biochem Pharmacol 2009;78:1360-1365.
5. Benazzi F. Bipolar disorder-focus on bipolar II disorder and mixed depression. Lancet 2007;369:935-939.
6. Arajarvi R, Ukkola J, Haukka J , Suvisaari J , Hintikka J, Partonen T, Lonnqvist J. Psychosis among ‘‘healthy’’ siblings of schizophrenia patients. BMC Psychiatry 2006;6:6.
7. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Boil psychiatry 2000;48:531-538.
8. Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B (Neuropsychiatric Genetics) 2004;128B:61-64.
9. Valles V, van Os J, Guillamat R, Gutierrez B, Campillo M, Gento P, Fananas L. Increased morbid risk for schizophrenia in families of in-patients with bipolar illness. Schizophr Res 2000;42:83-90.
10. Craddock N, O’Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bull 2006;32:9-16.
11. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neuros 2007;61:3-19.
12. Gelder M, Harrison P, Couen P. Shorter of textbook of psychiatry 5ed May 2006: Oxford University Press.
13. Gothelf D, Law AJ, Frisch A, Chen J, Zarchi O, Michaelovsky E, Ren-Patterson R, Lipska BK, Carmel M, Kolachana B, Weizman A, Weinberger DR. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome. Biol Psychiatry 2014;75:406-413.
14. Mansell W, Pedley R. The ascent into mania: A review of psychological processes associated with the development of manic symptoms. Clin Psycholo Rev 2008;28: 494-520.
15. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O'Donovan MC. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73:152-161.
16. Lotta T, Vidgren J,Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-4210.
17. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM, Herman MM, Weinberger DR, Kleinman JE.Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003;28:1521-1530.
18. Tenhunen J, Salminen M, Jalanko A, Ukkonen S, Ulmanen I. Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol 1993;12: 253-263.
19. Rutherford K, Daggett V. A hotspot of inactivation: The A22S and V108M polymorphisms individually destabilize the active site structure of catechol O-methyltransferase. Biochemistry 2009;48:6450-6460.
20. Williams HJ, Owen MJ, O’Donovan MC. Is COMT a susceptibility gene for schizophrenia? Schizophrenia Bull 2007;33:635-641.
21. Lajin B, Alachkar A, Hamzeh AR, Michati R, Alhaj H. No association between Val158Met of the COMT gene and susceptibility to schizophrenia in the Syrian population. North Am J Med Sci 2011;3:176-178.
22. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatry Genet 1998;8:221-225.
23. Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. A highly significant association between a COMT haplotype and schizophrenia.Am J Hum Genet 2002;71:1296-1302.
24. Cordeiro Q, Silva RT, Vallada H. Association study between the rs165599 catechol-O-methyltransferase genetic polymorphism and schizophrenia in a Brazilian sample. Arq Neuropsiquiatr 2012;70:913-916.